Fluofarma Overview
- Founded
-
2003

- Status
-
Acquired/Merged
- Employees
-
17

- Latest Deal Type
-
M&A
Fluofarma General Information
Description
Provider of content analysis technologies to perform and develop cell-based assays. The company offers following services including assay development, cell-based screening, drug profiling, predictive toxicology, biomarker analysis in blood and tissues.
Contact Information
Website
www.fluofarma.com
Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Monitoring Equipment
Acquirer
Primary Office
- 2 rue Robert Escarpit
- 33600 Pessac
- France
Fluofarma Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 10-Dec-2015 | Completed | Generating Revenue | |||
1. Accelerator/Incubator | Completed | Startup |
Fluofarma Patents
Fluofarma Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20150131887-A1 | System and method to visualize and analyze data from image-based cellular assays or high content screening | Inactive | 15-Apr-2011 | 000000000 |
Fluofarma Signals
Fluofarma Former Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Incubateur Régional d'Aquitaine | Accelerator/Incubator | 000 0000 | 000000 0 |